Filter Search


Healthcare and Medical


Location Summary Deadline
Germany The Aok Rheinland-pfalz/saarland - Die Gesundheitskasse Offers All Interested Pharmaceutical Companies Non-exclusive Discount Contracts For The Active Ingredient Piribedil. The Contracts Are Concluded Within The Framework Of An ''open House Model''. The O 2026-03-15
Germany The Aok Bayern Intends To Enter Into Non-exclusive Discount Agreements With All Interested Pharmaceutical Companies For The Active Ingredient Octreotide, Atc H01cb02, According To § 130a Abs. 8 Sgb V. The Contracts Will Be Identical And Non-negotiable, Wi 2026-03-15
Germany Open House Pharmaceutical Dact Treaties For The Active Ingredient Clonidine, Atc C02ac01 2026-03-16
Germany Open House Pharmaceutical Discounts On The Active Ingredient Ethosuximide, Atc N03ad01 2026-03-16
Germany Open House Pharmaceutical Dact Treaties For The Active Ingredient Clomipramin, Atc N06aa04 2026-03-16
Germany Open House Pharmaceutical Discounts On The Active Ingredient Natalizumab, S.c. Daring Form, Atc L04ag03 2026-03-16
Germany Open House Pharmaceutical Dact Treaties Timolol And Brinzolamid, Atc S01ed67 2026-03-16
Germany Open House Pharmaceutical Dact Treaties Timolol And Tafluprost, Atc S01ed70 2026-03-16
Germany Open House Pharmaceutical Discount Contracts Tiotropium Bromide, In The Dosage Form Inhalation Solution (resp Toimate (r)), Atc R03bb04 2026-03-16
Germany Open House Pharmaceutical Discounts On The Active Ingredient Teriparatide, Atc H05aa02 2026-03-16
Whats app